Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Lexeo Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 0 | 31 | +31 |
| Shares | 0 | 16.2M | +16.2M |
| Value | $0 | $217.1M | +$217.1M |
New holders (31)
Institutions that held Lexeo Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (0)
Institutions that held Lexeo Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
None.